ALB and neoplasm: The patient subsequently underwent neoadjuvant therapy comprising albumin-bound paclitaxel, camrelizumab, oxaliplatin, and S-1.After four cycles, the tumor significantly reduced in size, with restaging at yT2N2M0 (Stage IIb).